Advancements in immunotherapy for hepatocellular carcinoma
2025 · Expert Review of Anticancer Therapy · 3 citations
https://doi.org/10.1080/14737140.2025.2461631
P
Piera Federico
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
94
Papers
1.7K
Citations
25
h-index
34
i10-index
Piera Federico is an academic researcher. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Myasthenia Gravis and Thymoma & Colorectal Cancer Treatments and Studies. The author has an h-index of 25, co-authored 80 publications.
ORCID: 0000-0002-0863-7546Papers by this author
worksStatins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab
2025 · Scientific Reports · 1 citations
https://doi.org/10.1038/s41598-025-25752-4
Supplementary Material for: Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.14787696
THU-472-YI Sorafenib as a second-line treatment after failure of Atezolizumab/Bevacizumab
2024 · Journal of Hepatology · 0 citations
https://doi.org/10.1016/s0168-8278(24)01397-7
SAT-477-YI The impact of etiologyon patterns of progression of advanced HCC
2024 · Journal of Hepatology · 0 citations
https://doi.org/10.1016/s0168-8278(24)01279-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat